ImportRefusal LogoImportRefusal

Glaxosmithkline -Onology Chemistry

⚠️ Moderate Risk

FEI: 3006388565 • Durham, NC • UNITED STATES

FEI

FEI Number

3006388565

📍

Location

Durham, NC

🇺🇸
🏢

Address

2512 S Tridenter Blvd Block 16-18, , Durham, NC, United States

Moderate Risk

FDA Import Risk Assessment

28.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
1
Unique Violations
11/20/2012
Latest Refusal
11/20/2012
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1791×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

Refusal History

DateProductViolationsDivision
11/20/2012
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Glaxosmithkline -Onology Chemistry's FDA import refusal history?

Glaxosmithkline -Onology Chemistry (FEI: 3006388565) has 1 FDA import refusal record(s) in our database, spanning from 11/20/2012 to 11/20/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmithkline -Onology Chemistry's FEI number is 3006388565.

What types of violations has Glaxosmithkline -Onology Chemistry received?

Glaxosmithkline -Onology Chemistry has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxosmithkline -Onology Chemistry come from?

All FDA import refusal data for Glaxosmithkline -Onology Chemistry is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.